ホーム › 胆管癌（胆管細胞癌） › ニューヨーク
ニューヨークにおける胆管癌（胆管細胞癌）の臨床試験
ニューヨーク内の拠点で、胆管癌（胆管細胞癌）に関する15件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
- Roswell Park Cancer Institute, Buffalo
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06728410A Study of PHST001 in Advanced Solid Tumors
- START Center for Cancer Research - Long Island New York, Lake Success
- Mount Sinai, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New York Long Island LLC, Lake Success
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- Rosewell Park Comprehensive Cancer Center (Site 114), Buffalo
- Memorial Sloan Kettering Cancer Center (Site 108), New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07265674A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- START New York, Lake Success
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07488676Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Memorial Sloan Kettering Cancer Centers, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06282575Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05732831Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
- Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04891289HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
- Montefiore Medical Center, The Bronx
被験者募集中
18歳以上 · 全性別 · 2026/08/11更新 · NCT06899152Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- New York Presbyterian Hospital-Columbia University Medical Center, New York
被験者募集中第4相
18歳以上 · 全性別 · 2026/08/11更新 · NCT07486713A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797A Study of MGC028 in Participants With Advanced Solid Tumors
- Icahn School of Medicine at Mt. Sinai, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/27更新 · NCT06723236SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- 他2件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774The Dragon PLC Trial (DRAGON-PLC)
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中
18歳以上 · 全性別 · 2025/05/15更新 · NCT06914648ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。